SCHEMBL1124265

SCHEMBL1124265

O=C(Cl)Cc1ccccc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
MAPK1 P28482 2/20 0.49
ALOX15 P16050 1/20 0.48
LMNA P02545 4/20 0.46
RAB9A P51151 2/20 0.46
TAAR1 Q96RJ0 1/20 0.45
CXCL8 P10145 2/20 0.44
CASP3 P42574 2/20 0.44
CASP7 P55210 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
MAPK8 P45983 1/20 0.43
PPIA P62937 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
NPC1 O15118 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30098315 1.00 ALDH1A1 (0.50) ALDH1A1MAPK1ALOX15LMNARAB9A
Methylene Chloride SCHEMBL28534416 0.96 ALDH1A1 (0.48) ALDH1A1MAPK1ALOX15LMNARAB9A
SCHEMBL6767819 0.84 AKR1B1 (0.46) ALDH1A1MAPK1RAB9ACXCL8NPC1
SCHEMBL1142802 0.83 CES2 (0.45) ALDH1A1ALOX15CXCL8MEN1KMT2A
SCHEMBL27383077 0.83 ALDH1A1 (0.49) ALDH1A1MAPK1LMNARAB9ATAAR1
SCHEMBL1031721 0.83 ALDH1A1 (0.55) ALDH1A1MAPK1LMNARAB9ATAAR1
SCHEMBL29639794 0.83 ALDH1A1 (0.55) ALDH1A1MAPK1LMNARAB9ATAAR1
SCHEMBL6969660 0.82 ALDH1A1 (0.51) ALDH1A1MAPK1LMNARAB9ATAAR1
SCHEMBL4661911 0.82 ALDH1A1 (0.51) ALDH1A1MAPK1LMNARAB9ATAAR1
SCHEMBL24977211 0.82 ANO1 (0.41) ALDH1A1MAPK1ALOX15TAAR1CXCL8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107011227-B Nitrine based on tubulin-beta-lactam Small-molecule probe and its preparation method and application 郑州大学 2019-08-09 CN claimed
CN-108191746-A A kind of novel hydroxyl pyridine compounds and preparation method and application 暨南大学 2018-06-22 CN claimed
CN-107011227-A Nitrine beta-lactam Small-molecule probe based on tubulin and its preparation method and application 郑州大学 2017-08-04 CN claimed
CN-104098535-A Preparation method for 4-(3-fluorine phenyl)-2,2-phenyl-5-(4-(methylmercapto-)phenyl) furan-3(2H)-ketone NANTONG HUAFENG CHEMICAL CO 2014-10-15 CN claimed
CN-101134739-A Novel beta-lactam compound and preparation method and chemical uses thereof CHANGCHUN DISCOVERY SCIENCES L (CN) 2008-03-05 CN claimed
EP-3729190-B1 ELECTROPHORETIC DISPLAY DEVICE AND ELECTRONIC APPARATUS E INK CORP (US) 2024-02-07 EP disclosed
EP-3901147-B1 ACYLAMINO BRIDGED HETEROCYCLIC COMPOUND, AND COMPOSITION AND APPLICATION THEREOF BEIJING SCITECH MQ PHARMACEUTICALS LTD (CN) 2023-11-22 EP disclosed
CN-109471330-B Photosensitive composition and photopolymerization initiator used therein 东京应化工业株式会社 2023-08-29 CN disclosed
US-20230159538-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS GLOBAL BLOOD THERAPEUTICS, INC. 2023-05-25 US disclosed
US-20230151016-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS GLOBAL BLOOD THERAPEUTICS INC (US) 2023-05-18 US disclosed
EP-4126876-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS Global Blood Therapeutics, Inc. (US) 2023-02-08 EP disclosed
US-11566030-B2 Substituted 2,6-dihydropyrrolo[3,4-c]pyrazoles as pyruvate kinase activators GLOBAL BLOOD THERAPEUTICS, INC. (US) 2023-01-31 US disclosed
US-4703052-A Hypoglycemic thiazolidinediones PFIZER INC. (US) 1987-10-27 US disclosed
EP-0207605-A1 Hypoglycemic thiazolidinediones PFIZER INC. (US) 1987-01-07 EP disclosed
WO-1986007056-A1 HYPOGLYCEMIC THIAZOLIDINEDIONES PFIZER INC. (US) 1986-12-04 WO disclosed
US-4473560-A Diphosphonic acid derivatives and pharmaceutical preparations containing them SCHERING AKTIENGESELLSCHAFT (DE) 1984-09-25 US disclosed
EP-0015690-B1 PENICILLIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THEM BEECHAM GROUP PLC (GB) 1983-04-06 EP disclosed
US-4308259-A Penicillin derivatives BEECHAM GROUP LIMITED (GB) 1981-12-29 US disclosed
EP-0015690-A1 Penicillin derivatives, process for their preparation and pharmaceutical composition comprising them BEECHAM GROUP PLC (GB) 1980-09-17 EP disclosed
US-3992396-A TRANQUILIZERS, HYPNOTICS SANDOZ, INC. (US) 1976-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11566030-B2 Substituted 2,6-dihydropyrrolo[3,4-c]pyrazoles as pyruvate kinase activators PDK1, PDK2, PDK3 ALDH1A1 1703/4885MAPK1 622/4885ALOX15 3911/4885
US-20230151016-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS PDK1, PDK2, PKM ALDH1A1 1784/4885MAPK1 383/4885ALOX15 3944/4885
US-20230159538-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS PDK1, PDK2, PKM ALDH1A1 1784/4885MAPK1 383/4885ALOX15 3944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.